Baker Douglas P's Form 4 filing
OptimizeRx Corp (OPRX) · filed Aug 17, 2021
- Accession no.
- 0001213900-21-043479
- Filed
- Aug 17, 2021
- Trade date
- Aug 13-17, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $550.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker Douglas PCIK 0001028775 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock (pursuant to 10B5-1 plan) | SSaleDisposed | −5,000 | $63.27 | −$316,350 | 67,796 | Direct | |
| Aug 17, 2021 | Common Stock (pursuant to 10B5-1 plan) | SSaleDisposed | −4,000 | $58.46 | −$233,840 | 63,796 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.